Skip to search.
 FTSE 100 Down 0.04%

VIVUS Inc. (VVUS)

-NasdaqGS
2.61 Down 0.08(2.97%) 27 Feb 21:00
|After Hours: : 2.61 0.00 (0.00%) 27 Feb 22:00
Add to Portfolio
Prev Close:2.69
Open:2.67
Bid:N/A
Ask:2.65 x 3300
1y Target Est:3.63
Beta:2.13
Earnings Date:4 May - 8 May (Est.)
Day's Range:2.54 - 2.68
52wk Range:2.41 - 6.40
Volume:2,466,013
Avg Vol (3m):2,102,960
Market Cap:270.66m
P/E (ttm):N/A
EPS (ttm):-0.80
Div & Yield:N/A (N/A)
Trade Now
Quotes delayed, except where indicated otherwise. Currency in USD.

Comparison

Symbol% ChgMkt Cap
VVUSDown 2.97%270.66m
LLYUp 0.20%74.42b
GSKDown 0.88%114.07b
PFEDown 0.78%216.24b

Key Statistics

Forward P/E (1 yr):N/A
P/S (ttm):2.44
Ex-Dividend Date:N/A

Analysts

Annual EPS Est (Dec-15) :-1.14
Quarterly EPS Est (Mar-15) :-0.23
Mean Recommendation*:3.3
PEG Ratio (5 yr expected):-0.34

* (Strong Buy) 1.0 - 5.0 (Sell)

Analyst Opinion | Estimates

Business Summary

VIVUS, Inc., a biopharmaceutical company, develops and commercializes therapies to address unmet needs in obesity, sleep apnea, diabetes, and sexual health in the United States and the European Union. more
Your browser doesn't support canvas
SETTINGS
Scrolling
Speed
Display
Price
Submit Feedback